|
|
|
Insider
Information: |
Dietz Thomas John |
Relationship: |
Director |
City: |
Pt. Richmond |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
21,000 |
|
Indirect Shares
|
50,000 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
71,000 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2023-09-21 |
0 |
2014-10-30 |
0 |
Premium* |
|
Celladon Corp |
CLDN |
Director |
2023-01-23 |
21,000 |
2023-01-23 |
50,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2023-09-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(69,250) |
0 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2023-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
70,000 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2023-01-23 |
4 |
B |
$1.43 |
$71,580 |
I/I |
50,000 |
50,000 |
2.1 |
- |
|
CLDN |
Celladon Corp |
|
|
2022-12-22 |
4 |
S |
$1.17 |
$26,303 |
D/D |
(22,500) |
21,000 |
0 |
- |
|
CLDN |
Celladon Corp |
|
|
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
43,500 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
50,000 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2021-04-09 |
4 |
B |
$8.48 |
$21,220 |
D/D |
2,500 |
37,500 |
2.39 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2021-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
35,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
30,000 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2020-03-16 |
4 |
B |
$4.95 |
$4,950 |
D/D |
1,000 |
30,000 |
2.31 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
29,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
21,000 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2020-01-10 |
4 |
B |
$13.94 |
$55,760 |
D/D |
4,000 |
24,000 |
2.39 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2019-04-23 |
4 |
B |
$11.10 |
$55,495 |
D/D |
5,000 |
20,000 |
2.39 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
12,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2019-02-15 |
4 |
AS |
$7.14 |
$21,420 |
D/D |
(3,000) |
4,500 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2018-12-21 |
4 |
S |
$5.01 |
$46,743 |
D/D |
(9,330) |
7,500 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2018-12-20 |
4 |
B |
$9.98 |
$49,900 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2018-12-06 |
4 |
B |
$11.26 |
$56,300 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
16,830 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2018-02-05 |
4 |
AS |
$14.22 |
$29,862 |
D/D |
(2,100) |
9,330 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
11,430 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Director |
|
2014-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,430 |
5,430 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|